Thymoquinone: Fifty years of success in the battle against cancer models

Drug Discovery Today

Volumn 19, Issue 1, 2014, Pages 18-30

  Schneider Stock, Regine ^a   Fakhoury, Isabelle H ^b   Zaki, Angela M ^b   El Baba, Chirine O ^a   Gali Muhtasib, Hala U ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; THYMOQUINONE;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; COLON CANCER; CYTOTOXICITY; DIFFERENTIAL PULSE POLAROGRAPHY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STRUCTURE; GENE MUTATION; GENOMIC INSTABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VIVO STUDY; INFLAMMATORY DISEASE; MULTIPLE MYELOMA; NEOPLASM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; X RAY POWDER DIFFRACTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOQUINONES; DISEASE MODELS, ANIMAL; HUMANS; NEOPLASMS; NIGELLA SATIVA;

EID: 84891858462     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.08.021     Document Type: Review

References (106)

1. H. Gali-Muhtasib et al. Thymoquinone: a promising anti-cancer drug from natural sources Int. J. Biochem. Cell Biol. 38 2006 1249 1253
2. N.T. Trang et al. Thymoquinone from Eupatorium ayapana Planta Med. 59 1993 99
3. B. Lukas et al. Composition of essential oil compounds from different Syrian populations of Origanum syriacum L. (Lamiaceae) J. Agric. Food Chem. 57 2009 1362 1365
4. D.K. Manter et al. Antimicrobial activity of extractable conifer heartwood compounds toward Phytophthora ramorum J. Chem. Ecol. 33 2007 2133 2147
5. A.R. Gohari et al. Evaluation of the cytotoxicity of Satureja spicigera and its main compounds Sci. World J. 2012 2012 203861
6. C. Grosso et al. Composition and antioxidant activity of Thymus vulgaris volatiles: comparison between supercritical fluid extraction and hydrodistillation J. Sep. Sci. 33 2010 2211 2218
7. J. Hussain et al. Chemical constituents of Nepeta distans Nat. Prod. Commun. 5 2010 1785 1786
8. M.L. Salem Immunomodulatory and therapeutic properties of the Nigella sativa L. seed Int. Immunopharmacol. 5 2005 1749 1770
9. S. Banerjee et al. Review on molecular and therapeutic potential of thymoquinone in cancer Nutr. Cancer 62 2010 938 946
10. C.C. Woo et al. Thymoquinone: potential cure for inflammatory disorders and cancer Biochem. Pharmacol. 83 2012 443 451
11. J. Akhondian et al. The effect of thymoquinone on intractable pediatric seizures (pilot study) Epilepsy Res. 93 2011 39 43
12. M. El-Dakhakhny Studies on the chemical constitution of Egyptian N. sativa L. seeds Planta Med. 11 1963 465 470
13. D. Cremer et al. Toward a rationalization of the sensitizing potency of substituted p-benzoquinones: reaction of nucleophiles with p-benzoquinones J. Med. Chem. 30 1987 1678 1681
14. M.A. Mansour Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice Life Sci. 66 2000 2583 2591
15. O.A. Badary, and A.M. Gamal El-Din Inhibitory effects of thymoquinone against 20-methylcholanthrene-induced fibrosarcoma tumorigenesis Cancer Detect. Prev. 25 2001 362 368
16. H. Gali-Muhtasib et al. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells Cancer Res. 68 2008 5609 5618
17. E.M. Dergarabetian et al. Thymoquinone induces apoptosis in malignant T-cells via generation of ROS Front. Biosci. (Elite Ed.) 5 2013 706 719
18. S. Rooney, and M.F. Ryan Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells Anticancer Res. 25 2005 4255 4259
19. W. Reindl et al. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions Chem. Biol. 15 2008 459 466
20. K.H. Khalife, and G. Lupidi Nonenzymatic reduction of thymoquinone in physiological conditions Free Radic. Res. 41 2007 153 161
21. Z. Yin et al. Thymoquinone blocks pSer/pThr recognition by Plk1 Polo-box domain as a phosphate mimic ACS Chem. Biol. 8 2013 303 308
22. J. Yuan et al. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo Am. J. Pathol. 179 2011 2091 2099
23. S.A. Pathan et al. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies Biomed. Chromatogr. 25 2011 613 620
24. K. Effenberger-Neidnicht et al. Cellular localisation of antitumoral 6-alkyl thymoquinones revealed by an alkyne-azide click reaction and the streptavidin-biotin system Chembiochem 12 2011 1237 1241
25. K. Effenberger et al. Terpene conjugates of the Nigella sativa seed-oil constituent thymoquinone with enhanced efficacy in cancer cells Chem. Biodivers. 7 2010 129 139
26. S. Banerjee et al. Structure-activity studies on therapeutic potential of thymoquinone analogs in pancreatic cancer Pharm. Res. 27 2010 1146 1158
27. J. Ravindran et al. Thymoquinone poly(lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential Biochem. Pharmacol. 79 2010 1640 1647
28. G.M. Ganea et al. Delivery of phytochemical thymoquinone using molecular micelle modified poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles Nanotechnology 21 2010 285104
29. F. Odeh et al. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer Drug Deliv. 19 2012 371 377
30. M. Shah et al. Synthesis and characterization of PHV-block-mPEG diblock copolymer and its formation of amphiphilic nanoparticles for drug delivery J. Nanosci. Nanotechnol. 11 2011 5702 5710
31. M. Shah et al. Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation Int. J. Pharm. 400 2010 165 175
32. A. Singh et al. Nanocarrier based formulation of thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies Colloids Surf. B: Biointerfaces 102 2013 822 832
33. S. Alam et al. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study Int. J. Nanomed. 7 2012 5705 5718
34. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
35. S. Banerjee et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer Cancer Res. 69 2009 5575 5583
36. A.O. Kaseb et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer Cancer Res. 67 2007 7782 7788
37. P.S. Koka et al. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species Exp. Biol. Med. (Maywood) 235 2010 751 760
38. N. El-Najjar et al. Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling Apoptosis 15 2010 183 195
39. D.R. Worthen et al. The in vitro anti-tumor activity of some crude and purified components of blackseed, Nigella sativa L Anticancer Res. 18 1998 1527 1532
40. G. Badr et al. Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis PLoS ONE 6 2011 E23741
41. S. Das et al. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma PLoS ONE 7 2012 E46641
42. T. Yi et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways Mol. Cancer Ther. 7 2008 1789 1796
43. S.A. Arafa el et al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells Mutat. Res. 706 2011 28 35
44. A.R. Hussain et al. Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma Free Radic. Biol. Med. 50 2011 978 987
45. M.P. Torres et al. Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies Mol. Cancer Ther. 9 2010 1419 1431
46. H. Gali-Muhtasib et al. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism Int. J. Oncol. 25 2004 857 866
47. M. Alhosin et al. Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1 Biochem. Pharmacol. 79 2010 1251 1260
48. F. Li et al. Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway Br. J. Pharmacol. 161 2010 541 554
49. H.U. Gali-Muhtasib et al. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes Anticancer Drugs 15 2004 389 399
50. R.L. Gurung et al. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells PLoS ONE 5 2010 E12124
51. C.C. Woo et al. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathway Biochem. Pharmacol. 82 2011 464 475
52. M.A. El-Mahdy et al. Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells Int. J. Cancer 117 2005 409 417
53. M. Roepke et al. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells Cancer Biol. Ther. 6 2007 160 169
54. R. El Mezayen et al. Effect of thymoquinone on cyclooxygenase expression and prostaglandin production in a mouse model of allergic airway inflammation Immunol. Lett. 106 2006 72 81
55. M. El-Dakhakhny et al. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipoxygenase products in polymorphonuclear leukocytes from rats J. Ethnopharmacol. 81 2002 161 164
56. M.A. El Gazzar et al. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation Biochim. Biophys. Acta 1770 2007 556 564
57. G. Sethi et al. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis Mol. Cancer Res. 6 2008 1059 1070
58. N. Chehl et al. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells HPB (Oxford) 11 2009 373 381
59. W.K. Ng et al. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein Toxicol. In Vitro 25 2011 1392 1398
60. K.M. Sutton et al. NADPH quinone oxidoreductase 1 mediates breast cancer cell resistance to thymoquinone-induced apoptosis Biochem. Biophys. Res. Commun. 426 2012 421 426
61. M. Alhosin et al. Anti-neoplastic agent thymoquinone induces degradation of alpha and beta tubulin proteins in human cancer cells without affecting their level in normal human fibroblasts Invest. New Drugs 30 2012 1813 1819
62. A. Abusnina et al. Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis Cell Signal. 23 2011 152 160
63. A. Paramasivam et al. Anti-cancer effects of thymoquinone in mouse neuroblastoma (Neuro-2a) cells through caspase-3 activation with down-regulation of XIAP Toxicol. Lett. 213 2012 151 159
64. S.H. Jafri et al. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo J. Exp. Clin. Cancer Res. 29 2010 87
65. H. Gali-Muhtasib et al. Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models J. Cell Mol. Med. 12 2008 330 342
66. K. Kolli-Bouhafs et al. Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation Invest. New Drugs 30 2012 2121 2131
67. Z.H. Wu et al. Anti-metastasis effect of thymoquinone on human pancreatic cancer Yao Xue Xue Bao 46 2011 910 914
68. N. Farah et al. The effects of isolated antioxidants from black seed on the cellular metabolism of A549 cells Biomed. Sci. Instrum. 41 2005 211 216
69. T.M. Martin et al. The effect of conventional and sustained delivery of thymoquinone and levodopa on SH-SY5Y human neuroblastoma cells Biomed. Sci. Instrum. 42 2006 332 337
70. A.A. Norwood et al. Comparison of potential chemotherapeutic agents, 5-fluoruracil, green tea, and thymoquinone on colon cancer cells Biomed. Sci. Instrum. 42 2006 350 356
71. F. Wilson-Simpson et al. Physiological responses of ES-2 ovarian cell line following administration of epigallocatechin-3-gallate (EGCG), thymoquinone (TQ), and selenium (SE) Biomed. Sci. Instrum. 43 2007 378 383
72. R. Ulu et al. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury Food Chem. Toxicol. 50 2012 1675 1679
73. M.N. Nagi, and M.A. Mansour Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity in rats: a possible mechanism of protection Pharmacol. Res. 41 2000 283 289
74. O.A. al-Shabanah et al. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity J. Exp. Clin. Cancer Res. 17 1998 193 198
75. F.Q. Alenzi et al. Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide Br. J. Biomed. Sci. 67 2010 20 28
76. M.N. Nagi et al. Thymoquinone supplementation attenuates cyclophosphamide-induced cardiotoxicity in rats J. Biochem. Mol. Toxicol. 25 2011 135 142
77. G.M. Suddek et al. Thymoquinone attenuates cyclophosphamide-induced pulmonary injury in rats Inflammopharmacology 2012 1 9 10.1007/s10787-012-0160-6 [Epub ahead of print]
78. O.A. Badary et al. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats Toxicology 143 2000 219 226
79. 50 of thymoquinone, an active principle of Nigella sativa, in mice and rats J. Ayub. Med. Coll. Abbottabad 20 2008 25 27
80. A.M. Al-Amri, and A.O. Bamosa Phase I safety and clinical activity study of thymoquinone in patients with advanced refractory malignant disease Shiraz Med. J. 10 2009 107 111
81. M.F. Zafeer et al. Cadmium-induced hepatotoxicity and its abrogation by thymoquinone J. Biochem. Mol. Toxicol. 26 2012 199 205
82. A. Nili-Ahmadabadi et al. Protective effect of pretreatment with thymoquinone against Aflatoxin B(1) induced liver toxicity in mice Daru 19 2011 282 287
83. M.H. Daba, and M.S. Abdel-Rahman Hepatoprotective activity of thymoquinone in isolated rat hepatocytes Toxicol. Lett. 95 1998 23 29
84. M.N. Nagi et al. Thymoquinone supplementation reverses acetaminophen-induced oxidative stress, nitric oxide production and energy decline in mice liver Food Chem. Toxicol. 48 2010 2361 2365
85. F. Basarslan et al. Protective effects of thymoquinone on vancomycin-induced nephrotoxicity in rats Hum. Exp. Toxicol. 31 2012 726 733
86. A.M. Fouda et al. Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats Basic Clin. Pharmacol. Toxicol. 103 2008 109 118
87. M.M. Sayed-Ahmed, and M.N. Nagi Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats Clin. Exp. Pharmacol. Physiol. 34 2007 399 405
88. M. Kanter Nigella sativa and derived thymoquinone prevents hippocampal neurodegeneration after chronic toluene exposure in rats Neurochem. Res. 33 2008 579 588
89. M. Kanter et al. Gastroprotective activity of Nigella sativa L. oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats World J. Gastroenterol. 11 2005 6662 6666
90. D. Al-Johar et al. Role of Nigella sativa and a number of its antioxidant constituents towards azoxymethane-induced genotoxic effects and colon cancer in rats Phytother. Res. 22 2008 1311 1323
91. H.J. Harzallah et al. Thymoquinone, the Nigella sativa bioactive compound, prevents circulatory oxidative stress caused by 1,2-dimethylhydrazine in erythrocyte during colon postinitiation carcinogenesis Oxid. Med. Cell Longev. 2012 2012 854065
92. M. Kanter Thymoquinone attenuates lung injury induced by chronic toluene exposure in rats Toxicol. Ind. Health 27 2011 387 395
93. A. Gokce et al. Protective effects of thymoquinone against methotrexate-induced testicular injury Hum. Exp. Toxicol. 30 2011 897 903
94. S. Ivankovic et al. The antitumor activity of thymoquinone and thymohydroquinone in vitro and in vivo Exp. Oncol. 28 2006 220 224
95. Y.M. Wang Inhibitory effects of thymoquinone on human pancreatic carcinoma orthotopically implanted in nude mice Zhonghua Yi Xue Za Zhi 91 2011 3111 3114
96. H.Q. Mu et al. Role of NF-kappaB in the anti-tumor effect of thymoquinone on bladder cancer Zhonghua Yi Xue Za Zhi 92 2012 392 396
97. M. Tan et al. Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture Biomed. Sci. Instrum. 42 2006 363 371
98. L.R. Richards et al. LNCaP cells exposed to ceramic drug delivery treatment with epigallocatechin-3-gallate, thymoquinone, and tannic acid Biomed. Sci. Instrum. 43 2007 242 247
99. X. Lei et al. Thymoquinone prevents and ameliorates dextran sulfate sodium-induced colitis in mice Dig. Dis. Sci. 57 2012 2296 2303
100. O.A. Badary Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice J. Ethnopharmacol. 67 1999 135 142
101. O.A. Badary et al. Inhibition of benzo(a)pyrene-induced forestomach carcinogenesis in mice by thymoquinone Eur. J. Cancer Prev. 8 1999 435 440
102. J. Brewer et al. Effects of thymoquinone, lycopene, and selenomethione in the presence of estrogen on the viability of SiHa cells in vitro Biomed. Sci. Instrum. 42 2006 37 41
103. L. Ross Richards et al. The role of estrogen, testosterone, and parathyroid hormones in combination with conventional and sustained antioxidant treatment on lncap cells - biomed 2009 Biomed. Sci. Instrum. 45 2009 268 273
104. R. Velho-Pereira et al. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis Cell Biol. Int. 35 2011 1025 1029
105. N. El-Najjar et al. Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone J. Chem. Biol. 4 2011 97 107
106. V.K. Gupta et al. Nanoparticle formulation for hydrophilic & hydrophobic drugs Int. J. Res. Pharm. Sci. 1 2010 163 169